Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 331 followers
Latest posts
Last updated about 13 hours ago
Human medicines European public assessment report (EPAR): Ruconest, conestat alfa, Date of authorisation: 28/10/2010, Revision: 16, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Ruconest, conestat alfa, Date of...
Human medicines European public assessment report (EPAR): Feraccru, ferric maltol, Date of authorisation: 18/02/2016, Revision: 19, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Feraccru, ferric maltol, Date of...
Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Date of authorisation: 16/07/2021, Revision: 8, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Date of...
Human medicines European public assessment report (EPAR): Xofluza, baloxavir marboxil, Date of authorisation: 07/01/2021, Revision: 9, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Xofluza, baloxavir marboxil, Date of...
Data Analysis and Real World Interrogation Network (DARWIN EU)
about 13 hours ago
Data Analysis and Real World Interrogation Network (DARWIN EU)
Human medicines European public assessment report (EPAR): Mimpara, cinacalcet, Date of authorisation: 22/10/2004, Revision: 27, Status: Withdrawn
about 14 hours ago
Human medicines European public assessment report (EPAR): Mimpara, cinacalcet, Date of authorisation...
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 12 October 2026 to 16 October 2026
about 14 hours ago
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU...
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 7 December 2026 to 11 December 2026
about 14 hours ago
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU...
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 9 November 2026 to 13 November 2026
about 14 hours ago
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU...
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 14 September 2026 to 18 September 2026
about 14 hours ago
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU...
Human medicines European public assessment report (EPAR): Iloperidone Vanda Pharmaceuticals, iloperidone, Status: Opinion
about 16 hours ago
Human medicines European public assessment report (EPAR): Iloperidone Vanda Pharmaceuticals, iloperidone, Status...
HMPC meeting report on European Union herbal monographs, guidelines and other activities - 4-6 May 2026
about 17 hours ago
HMPC meeting report on European Union herbal monographs, guidelines and other activities...